Volpara Solutions Limited

In the first large-scale study of its kind, Dutch researchers demonstrated a strong linear relationship between decreased screening performance and volumetric breast density. Involving more than 110,000 mammograms from the Dutch Breast Screening Program (Foundation of Population Screening Mid-West), the study showed that increasing volumetric breast density, automatically measured by Volpara Density software, impacts mammography performance measures, such as sensitivity and the rates of recall, false positives and interval cancers.

Volpara Solutions announced the launch of a support program to help accredited breast imaging centers across the United States prepare for compliance to the U.S. Food and Drug Administration’s (FDA) Enhancing Quality Using the Inspection Program (EQUIP) initiative. The Volpara "EQUIP-ready" program — which includes draft processes, procedures and forms designed to help users accelerate their compliance efforts — is included with the company's Volpara Enterprise cloud-based quality assurance solution.

For all the benefits of medical diagnostic imaging, radiation exposure to both the patient and the operator remains a major safety concern. Various studies have illustrated the harmful effects of excess radiation dose, but much is still uncertain as to its precise impact.

Based on its recent analysis of the breast density assessment solutions market, Frost & Sullivan recognizes Volpara Solutions with the 2016 Global Frost & Sullivan Award for Competitive Strategy Innovation and Leadership.

Volpara Solutions announced that it has received a new 510(k) clearance from the U.S. Food & Drug Administration (FDA) for Volpara Density Maps.